Accessibility Menu
Exscientia logo

Exscientia

(NASDAQ) EXAI

This security has been delisted. This page is retained for historical reference.

Exscientia last closing stock price
MetricPriceDate
Last closeUSD 4.842024-11-19
Exscientia stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-16.84%USD 5.822024-11-12
1 month-7.1%USD 5.212024-10-18
3 month-16.98%USD 5.832024-08-21
Year to date-24.49%USD 6.412023-12-29
1 year-16.84%USD 5.822023-11-20
3 year-76.45%USD 20.552021-11-19
Since inception-82.14%USD 27.102021-10-01

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

EXAI Financials

Key Financial Metrics (TTM)

Gross Margin

-36.48%

Operating Margin

-876.56%

Net Income Margin

-726.94%

Return on Equity

-38.96%

Return on Capital

-46.59%

Return on Assets

-28.58%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

N/A

Volume

N/A

Avg. Volume

N/A

Financials (TTM)

Gross Profit

-£11.56M

Operating Income

-£167.66M

EBITDA

-£135.58M

Operating Cash Flow

-£102.62M

Capital Expenditure

-£15.91M

Free Cash Flow

-£118.53M

Cash & ST Invst.

£244.08M

Total Debt

£18.57M

Exscientia Performance Analysis

Exscientia annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20212021-12-31GBP 37,626,938N/A
20222022-12-31GBP 33,532,752-10.9%
20232023-12-31GBP 24,959,238-25.6%
20242024-12-31GBP 0N/A
Exscientia sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42023-12-31-72.6%
Q12024-03-31117.7%
Q22024-06-30-16.5%
Q32024-09-3011.6%
Exscientia annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20212021-12-31GBP -0.56N/A
20222022-12-31GBP -1.20113.8%
20232023-12-31GBP -1.4622.0%
Exscientia sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42023-12-31-32.0%
Q12024-03-3148.5%
Q22024-06-30-70.6%
Q32024-09-30-41.4%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q3 2024YOY CHG

Revenue

£4.93M

-44.5%

Gross Profit

-£2.60M

-221.5%

Gross Margin

-52.74%

N/A

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

N/A

N/A

Employees

483

N/A

Net Income

-£52.13M

-67.0%

EBITDA

-£47.00M

-62.4%

Quarterly Fundamentals

Name
Q3 2024YOY CHG

Total Cash

£244.08M

-33.4%

Total Debt

£18.57M

+1.5%

Accounts Receivable

£49.62M

+147.8%

Inventory

£0.00

N/A

Long Term Debt

£15.40M

-3.8%

Short Term Debt

£3.17M

+37.6%

Return on Assets

-28.58%

N/A

Return on Invested Capital

-39.49%

N/A

Free Cash Flow

-£44.81M

-17.4%

Operating Cash Flow

-£36.78M

-7.7%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
IKNAIkena Oncology, Inc.
$17.16+1152.55%
SAGESage Therapeutics, Inc.
$8.68+0.00%
NAGENiagen Bioscience Inc
$3.40-2.02%
RGLSRegulus Therapeutics Inc.
$8.16+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
AALAmerican Airlines Group
$15.60-0.00%
ATAIAtaiBeckley
$7.15+0.33%
NOKNokia
$10.38-0.08%
ONDSOndas
$6.65-0.06%

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.